Volume 31, Number 6—June 2025
Dispatch
Mycoplasma arginini Cellulitis, Tenosynovitis, and Arthritis in Kidney Transplant Recipient, Slovenia, 2024
Tjaša Vivoda, Tereza Rojko, Barbara Kokošar Ulčar, Katja Strašek Smrdel, Andraž Celar Šturm, Darja Keše, Tina Triglav, and Željka Večerić Haler
Table
Laboratory values for Mycoplasma arginini cellulitis, tenosynovitis, and arthritis in kidney transplant recipient, Slovenia, 2024*
| Variable | Sample collection |
Reference range | |||
|---|---|---|---|---|---|
| At clinic† | At admission | At discharge | After treatment‡ | ||
| White blood count, cells × 109/L | 5.5 | 4.2 | 5.5 | 6.8 | 4.0–10.0 |
| C-reactive protein, mg/L | 5 | 40 | 13 | <5 | <5 |
| Procalcitonin, µg/L | 0.6 | 0.10 | 0.05 | NA | <0.24 |
| IgG, g/L | NA | 2.7 | 14.7§ | 6.1 | 7.67–15.90 |
| IgA, g/L | NA | <0.24 | <0.24 | NA | 0.61–3.56 |
| IgM, g/L | NA | <0.17 | 0.24 | NA | 0.37–2.86 |
| β-d-glucan, pg/mL | 189.3 | 207.2 | 170.2 | 192 | <59.9 |
| GM antigen, ELISA index | 0.06 | 0.12 | NA | NA | <0.5 |
| Cryptococcal antigen, ELISA titer | 1:0.03 | 1:0.04 | NA | NA | <1:1 |
| Blood cultures¶ | NA | Negative | NA | NA | Negative |
*IgG values were adjusted on the basis of presence of known IgG/κ spike. GM, galactomannan; NA, not available. †The patient’s clinic at symptom onset. ‡Treatment included a completed 6-week course of doxycycline. §Higher IgG concentration after administration of intravenous immunoglobulin. ¶Bactec FX Blood Culture System (Becton, Dickinson and Company, https://www.bd.com).
Page created: April 14, 2025
Page updated: May 27, 2025
Page reviewed: May 27, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.